Monitoring and Assessment Regular monitoring during IVIG therapy includes: Pain and symptom scores Quality of life measurements Repeat neurological examinations Sometimes repeat skin biopsies to assess nerve fiber density Blood tests for kidney function, blood counts, and immunoglobulin levels Potential Side Effects and Considerations While generally well-tolerated, IVIG can cause side effects including: Headache and flu-like symptoms Infusion site reactions Allergic responses Thromboembolic events (blood clots) Aseptic meningitis (rare) Renal dysfunction (particularly with pre-existing kidney issues) Patients with certain conditions, such as IgA deficiency, cardiac disease, or renal impairment, require special considerations before initiating IVIG
Moreover, it can inhibit the adhesion of leukocytes and platelets to the vessel walls [50, 51], contributing to preventing thrombus formation
Researchers interested in the benefits beyond weight loss often find that the 60 mg format provides enough supply to experiment with dosing variations while maintaining a consistent peptide source
These materials specifically purify GST-tagged GFP
Without identifying the source of irritation, treatment becomes guesswork and often fails
10.1096/fj.06-6722com FASEB J